Back to Treatments

Treatment

FOLFIRINOX (Folinic acid, Fluorouracil, Irinotecan, Oxaliplatin)

1
Conditions
100
Trials
3,000
Participants
25%
Average Safety

Condition Evidence

Pancreatic cancer

100 trials · 3,000 participants

80% effectiveness · 25% safety
FOLFIRINOX (Folinic acid, Fluorouracil, Irinotecan, Oxaliplatin) | DFDA